Glycosylphosphatidylinositol-anchored Protein Deficiency Confers Resistance to Apoptosis in PNH
Overview
Authors
Affiliations
Objective: Investigate the contribution of PIG-A mutations to clonal expansion in paroxysmal nocturnal hemoglobinuria (PNH).
Materials And Methods: Primary CD34+ hematopoietic progenitors from PNH patients were assayed for annexin-V positivity by flow cytometry in a cell-mediated killing assay using autologous effectors from PNH patients or allogeneic effectors from healthy controls. To specifically assess the role of the PIG-A mutation in the development of clonal dominance and address confounders of secondary mutation and differential immune attack that can confound experiments using primary cells, we established an inducible PIG-A CD34+ myeloid cell line, TF-1. Apoptosis resistance was assessed after exposure to allogeneic effectors, NK92 cells (an interleukin-2-dependent cell line with the phenotype and function of activated natural killer [NK] cells), tumor necrosis factor (TNF)-alpha, and gamma-irradiation. Apoptosis was measured by annexin-V staining and caspase 3/7 activity.
Results: In PNH patients, CD34+ hematopoietic progenitors lacking glycosylphosphatidylinositol (GPI)-anchored proteins (GPI-AP(-)) were less susceptible than GPI-AP+ CD34+ precursors to autologous (8% vs 49%; p < 0.05) and allogeneic (28% vs 58%; p < 0.05) cell-mediated killing from the same patients. In the inducible PIG-A model, GPI-AP(-) TF-1 cells exhibited less apoptosis than induced, GPI-AP+ TF-1 cells in response to allogeneic cell-mediated killing, NK92-mediated killing, TNF-alpha, and gamma-irradiation. GPI-AP(-) TF-1 cells maintained resistance to apoptosis when effectors were raised against GPI-AP(-) cells, arguing against a GPI-AP being the target of immune attack in PNH. NK92-mediated killing was partially inhibited with blockade by specific antibodies to the stress-inducible GPI-AP ULBP1 and ULBP2 that activate immune effectors. Clonal competition experiments demonstrate that the mutant clone expands over time under proapoptotic conditions with TNF-alpha.
Conclusion: PIG-A mutations contribute to clonal expansion in PNH by conferring a survival advantage to hematopoietic progenitors under proapoptotic stresses.
Eiko Yamakawa P, Perez Gomes C, Ribeiro Mendes A, Cesar Justino de Oliveira C, Porto Freitas F, Bettoni F Front Med (Lausanne). 2025; 12:1472186.
PMID: 40066167 PMC: 11891177. DOI: 10.3389/fmed.2025.1472186.
Ussowicz M, Przystupski D, Mensah-Glanowska P, Piekarska A Front Immunol. 2025; 15():1521484.
PMID: 39840046 PMC: 11747312. DOI: 10.3389/fimmu.2024.1521484.
Identification of Paroxysmal Nocturnal Hemoglobinuria-Type Bone Marrow Mast Cells.
Savasan S, Ozdemir O, Gadgeel M Cureus. 2023; 15(9):e44919.
PMID: 37814756 PMC: 10560574. DOI: 10.7759/cureus.44919.
Paroxysmal Nocturnal Hemoglobinuria: Biology and Treatment.
Bravo-Perez C, Guarnera L, Williams N, Visconte V Medicina (Kaunas). 2023; 59(9).
PMID: 37763731 PMC: 10535188. DOI: 10.3390/medicina59091612.
Pires da Silva B, Fonseca N, Catto L, Pereira G, Calado R Ann Hematol. 2022; 101(5):999-1007.
PMID: 35182190 PMC: 8993788. DOI: 10.1007/s00277-022-04797-9.